BRAF in metastatic colorectal cancer: the future starts now.

about

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.

P2860

Q38679229-4A609791-3907-4B2F-85EB-1D0939741BCE

P2860

BRAF in metastatic colorectal cancer: the future starts now.

Item

http://www.wikidata.org/entity/Q38652005

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

BRAF in metastatic colorectal cancer: the future starts now.

@en

type

Item

label

BRAF in metastatic colorectal cancer: the future starts now.

@en

prefLabel

BRAF in metastatic colorectal cancer: the future starts now.

@en

P1476

BRAF in metastatic colorectal cancer: the future starts now.

@en

P2093

Alessandra Calegari

http://www.w3.org/2001/XMLSchema#string

Ilaria Bossi

http://www.w3.org/2001/XMLSchema#string

Marta Caporale

http://www.w3.org/2001/XMLSchema#string

Rosa Berenato

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.

Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients.

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

P304

2069-2081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.140

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26615988

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

BRAF in metastatic colorectal cancer: the future starts now.

about

P2860

P2860

BRAF in metastatic colorectal cancer: the future starts now.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921